enow.com Web Search

  1. Ads

    related to: most common constipation medication for women over 65

Search results

  1. Results from the WOW.Com Content Network
  2. Lubiprostone - Wikipedia

    en.wikipedia.org/wiki/Lubiprostone

    Lubiprostone, sold under the brand name Amitiza among others, is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company.

  3. Prucalopride - Wikipedia

    en.wikipedia.org/wiki/Prucalopride

    Prucalopride, sold under brand names Resolor and Motegrity among others, is a medication acting as a selective, high affinity 5-HT 4 receptor agonist [4] which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements.

  4. Constipation - Wikipedia

    en.wikipedia.org/wiki/Constipation

    Constipation is the most common chronic gastrointestinal disorder in adults. Depending on the definition employed, it occurs in 2% to 20% of the population. [18] [58] It is more common in women, the elderly and children. [58] Specifically constipation with no known cause affects females more often affected than males. [59]

  5. The best 16 foods to relieve constipation fast ... - AOL

    www.aol.com/best-16-foods-relieve-constipation...

    A 2022 study found that two kiwi fruit a day was as effective as psyllium, found in many over-the-counter laxatives, in treating constipation. Foods to avoid when constipated

  6. Magnesium Supplements Can Help With Constipation, But Make ...

    www.aol.com/lifestyle/magnesium-supplements-help...

    Magnesium for constipation is a doctor-approved treatment. Experts recommend magnesium citrate or magnesium oxide, and say the oral route is most effective. Magnesium Supplements Can Help With ...

  7. Naloxegol - Wikipedia

    en.wikipedia.org/wiki/Naloxegol

    Naloxegol (INN; PEGylated naloxol; [4] trade names Movantik and Moventig) is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. [5] It was approved in 2014 in adult patients with chronic, non-cancer pain. [6]

  1. Ads

    related to: most common constipation medication for women over 65